SCHEMBL6587045

SCHEMBL6587045

COc1cccc(C(=O)NCCN2CCCC(C(=O)N3CCc4cc(OC)c(OC)cc4C3)C2)c1

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 8/20 0.57
DRD3 P35462 2/20 0.57
PDE4B Q07343 1/20 0.54
KDM2B Q8NHM5 3/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
DRD2 P14416 3/20 0.51
TMEM97 Q5BJF2 1/20 0.50
CCR3 P51677 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL6589754 0.98 DRD4 (0.55) DRD4DRD3PDE4BKDM2BMEN1
Hydrochloric Acid SCHEMBL6586295 0.89 KMT2A (0.54) DRD3PDE4BKDM2BMEN1KMT2A
SCHEMBL3991767 0.88 DRD3 (0.55) DRD4DRD3KDM2BMEN1KMT2A
SCHEMBL6587232 0.88 SIGMAR1 (0.51) DRD3PDE4BKDM2BMEN1KMT2A
SCHEMBL29773210 0.88 DRD3 (0.55) DRD4DRD3KDM2BMEN1KMT2A
SCHEMBL3991771 0.88 DRD3 (0.55) DRD4DRD3KDM2BMEN1KMT2A
SCHEMBL6589095 0.87 KMT2A (0.50) DRD4DRD3PDE4BKDM2BMEN1
Phosphoric Acid SCHEMBL3996528 0.85 DRD3 (0.53) DRD4DRD3KDM2BMEN1KMT2A
Phosphoric Acid SCHEMBL3996517 0.85 DRD3 (0.53) DRD4DRD3KDM2BMEN1KMT2A
SCHEMBL6587983 0.85 KDM4E (0.53) DRD3KDM2BMEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1186601-B1 NOVEL ISOQUINOLINE DERIVATIVES OR SALTS THEREOF YAMANOUCHI PHARMA CO LTD (JP) 2004-03-24 EP claimed
US-6573279-B1 Drug, particularly to a novel isoquinoline derivative or its salt having an If current inhibitory effect without serious side effects such as convulsion and also to a drug, particularly a cardiac rate lowering agent, containing the ASTELLAS PHARMA INC. (JP) 2003-06-03 US claimed
EP-1186601-A1 NOVEL ISOQUINOLINE DERIVATIVES OR SALTS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2002-03-13 EP claimed